News
Beijing-based biotech unicorn METiS TechBio has rolled out what it calls the world's first AI-powered nano-delivery platform, ...
Patients aged 10-50 are being sought for a clinical trial testing SAR446268, a gene therapy for myotonic dystrophy type 1 ...
This has put Trump, and Republicans more broadly, in a tricky spot. Kennedy has publicly derided Covid vaccines, canceled ...
Researchers at Tel Aviv University have developed a new approach for using locked nucleic acids (LNAs)—a particularly stable ...
Vertex shares fall nearly 24% in six months on pipeline setbacks but strong CF sales and new launches may shape the future.
Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to ...
Trump administration cuts to programs that study, track and prevent infectious diseases many Americans have never heard of ...
When doctors prescribe oxybutynin, it's usually for an unglamorous problem: bladder incontinence. But researchers have ...
After Health Secretary Robert F. Kennedy Jr. cut off funding for mRNA vaccine research, Congress advanced a spending plan ...
A research team at the University of Cologne and the Max Delbrück Center in Berlin has deciphered in detail the rules behind an important mechanism of cellular quality control in humans / Publication ...
A small-molecule compound named TAC has been identified that reawakens the catalytic subunit of telomerase (TERT) in somatic cells and, in doing so, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results